ID   HOT_HUMAN               Reviewed;         467 AA.
AC   Q8IWW8; B4DTJ8; Q49A19; Q68CI7; Q6P2B6; Q96MF9;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   10-MAY-2017, entry version 106.
DE   RecName: Full=Hydroxyacid-oxoacid transhydrogenase, mitochondrial;
DE            Short=HOT;
DE            EC=1.1.99.24 {ECO:0000269|PubMed:16435184};
DE   AltName: Full=Alcohol dehydrogenase iron-containing protein 1;
DE            Short=ADHFe1;
DE   AltName: Full=Fe-containing alcohol dehydrogenase;
DE   Flags: Precursor;
GN   Name=ADHFE1; ORFNames=HMFT2263;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=12592711; DOI=10.1080/1042517021000011636;
RA   Deng Y., Wang Z., Gu S., Ji C., Ying K., Xie Y., Mao Y.;
RT   "Cloning and characterization of a novel human alcohol dehydrogenase
RT   gene (ADHFe1).";
RL   DNA Seq. 13:301-306(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   ARG-449.
RC   TISSUE=Placenta, and Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 415-467, AND VARIANT
RP   ARG-449.
RC   TISSUE=Hepatoblastoma;
RX   PubMed=15221005; DOI=10.1038/sj.onc.1207782;
RA   Yamada S., Ohira M., Horie H., Ando K., Takayasu H., Suzuki Y.,
RA   Sugano S., Hirata T., Goto T., Matsunaga T., Hiyama E., Hayashi Y.,
RA   Ando H., Suita S., Kaneko M., Sasaki F., Hashizume K., Ohnuma N.,
RA   Nakagawara A.;
RT   "Expression profiling and differential screening between
RT   hepatoblastomas and the corresponding normal livers: identification of
RT   high expression of the PLK1 oncogene as a poor-prognostic indicator of
RT   hepatoblastomas.";
RL   Oncogene 23:5901-5911(2004).
RN   [6]
RP   FUNCTION, SUBSTRATE SPECIFICITY, CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16435184; DOI=10.1007/s10545-005-0114-x;
RA   Struys E.A., Verhoeven N.M., Ten Brink H.J., Wickenhagen W.V.,
RA   Gibson K.M., Jakobs C.;
RT   "Kinetic characterization of human hydroxyacid-oxoacid
RT   transhydrogenase: relevance to D-2-hydroxyglutaric and gamma-
RT   hydroxybutyric acidurias.";
RL   J. Inherit. Metab. Dis. 28:921-930(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-242.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Catalyzes the cofactor-independent reversible oxidation
CC       of gamma-hydroxybutyrate (GHB) to succinic semialdehyde (SSA)
CC       coupled to reduction of 2-ketoglutarate (2-KG) to D-2-
CC       hydroxyglutarate (D-2-HG). D,L-3-hydroxyisobutyrate and L-3-
CC       hydroxybutyrate (L-3-OHB) are also substrates for HOT with 10-fold
CC       lower activities. {ECO:0000269|PubMed:16435184}.
CC   -!- CATALYTIC ACTIVITY: (S)-3-hydroxybutanoate + 2-oxoglutarate =
CC       acetoacetate + (R)-2-hydroxyglutarate.
CC       {ECO:0000269|PubMed:16435184}.
CC   -!- CATALYTIC ACTIVITY: 4-hydroxybutanoate + 2-oxoglutarate = succinic
CC       semialdehyde + (R)-2-hydroxyglutarate.
CC       {ECO:0000269|PubMed:16435184}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.17 mM for GHB {ECO:0000269|PubMed:16435184};
CC         KM=1.2 mM for 2-KG {ECO:0000269|PubMed:16435184};
CC         KM=0.12 mM for D-2-HG {ECO:0000269|PubMed:16435184};
CC         KM=0.04 mM for SSA {ECO:0000269|PubMed:16435184};
CC         KM=0.8 mM for L-3-OHB {ECO:0000269|PubMed:16435184};
CC         Vmax=16 nmol/h/mg enzyme with GHB and 2-KG as substrates
CC         {ECO:0000269|PubMed:16435184};
CC         Vmax=0.5 nmol/h/mg enzyme with SSA and D-2-HG as substrates
CC         {ECO:0000269|PubMed:16435184};
CC         Vmax=1.8 nmol/h/mg enzyme with L-3-OHB and 2-KG as substrates
CC         {ECO:0000269|PubMed:16435184};
CC       pH dependence:
CC         Optimum pH is 7.5. {ECO:0000269|PubMed:16435184};
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8IWW8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IWW8-2; Sequence=VSP_031984;
CC       Name=3;
CC         IsoId=Q8IWW8-3; Sequence=VSP_031985, VSP_031986;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q8IWW8-4; Sequence=VSP_031984, VSP_031985, VSP_031986;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Only expressed in adult liver.
CC       {ECO:0000269|PubMed:12592711}.
CC   -!- SIMILARITY: Belongs to the iron-containing alcohol dehydrogenase
CC       family. Hydroxyacid-oxoacid transhydrogenase subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY033237; AAK44223.1; -; mRNA.
DR   EMBL; AK056992; BAB71335.1; -; mRNA.
DR   EMBL; AK300243; BAG62010.1; -; mRNA.
DR   EMBL; CH471068; EAW86902.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW86903.1; -; Genomic_DNA.
DR   EMBL; CH471068; EAW86907.1; -; Genomic_DNA.
DR   EMBL; BC064634; AAH64634.1; -; mRNA.
DR   EMBL; AB075879; BAD38661.1; -; mRNA.
DR   CCDS; CCDS6190.2; -. [Q8IWW8-1]
DR   RefSeq; NP_653251.2; NM_144650.2. [Q8IWW8-1]
DR   UniGene; Hs.720023; -.
DR   ProteinModelPortal; Q8IWW8; -.
DR   SMR; Q8IWW8; -.
DR   BioGrid; 126489; 2.
DR   IntAct; Q8IWW8; 2.
DR   STRING; 9606.ENSP00000379865; -.
DR   ChEMBL; CHEMBL4947; -.
DR   iPTMnet; Q8IWW8; -.
DR   PhosphoSitePlus; Q8IWW8; -.
DR   BioMuta; ADHFE1; -.
DR   DMDM; 74714449; -.
DR   PaxDb; Q8IWW8; -.
DR   PeptideAtlas; Q8IWW8; -.
DR   PRIDE; Q8IWW8; -.
DR   Ensembl; ENST00000396623; ENSP00000379865; ENSG00000147576. [Q8IWW8-1]
DR   Ensembl; ENST00000415254; ENSP00000407115; ENSG00000147576. [Q8IWW8-2]
DR   Ensembl; ENST00000424777; ENSP00000410883; ENSG00000147576. [Q8IWW8-3]
DR   GeneID; 137872; -.
DR   KEGG; hsa:137872; -.
DR   UCSC; uc003xwb.5; human. [Q8IWW8-1]
DR   CTD; 137872; -.
DR   DisGeNET; 137872; -.
DR   GeneCards; ADHFE1; -.
DR   HGNC; HGNC:16354; ADHFE1.
DR   HPA; HPA023062; -.
DR   MIM; 611083; gene.
DR   neXtProt; NX_Q8IWW8; -.
DR   OpenTargets; ENSG00000147576; -.
DR   PharmGKB; PA134871493; -.
DR   eggNOG; KOG3857; Eukaryota.
DR   eggNOG; COG1454; LUCA.
DR   GeneTree; ENSGT00390000003849; -.
DR   HOGENOM; HOG000243335; -.
DR   HOVERGEN; HBG057032; -.
DR   InParanoid; Q8IWW8; -.
DR   KO; K11173; -.
DR   OMA; RAACQCP; -.
DR   OrthoDB; EOG091G064B; -.
DR   PhylomeDB; Q8IWW8; -.
DR   TreeFam; TF105710; -.
DR   BRENDA; 1.1.99.24; 2681.
DR   Reactome; R-HSA-880009; Interconversion of 2-oxoglutarate and 2-hydroxyglutarate.
DR   GenomeRNAi; 137872; -.
DR   PRO; PR:Q8IWW8; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000147576; -.
DR   CleanEx; HS_ADHFE1; -.
DR   ExpressionAtlas; Q8IWW8; baseline and differential.
DR   Genevisible; Q8IWW8; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0004022; F:alcohol dehydrogenase (NAD) activity; IBA:GO_Central.
DR   GO; GO:0047988; F:hydroxyacid-oxoacid transhydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:InterPro.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; TAS:Reactome.
DR   GO; GO:0015993; P:molecular hydrogen transport; IDA:UniProtKB.
DR   InterPro; IPR001670; ADH_Fe.
DR   Pfam; PF00465; Fe-ADH; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Mitochondrion;
KW   Oxidoreductase; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transit peptide.
FT   TRANSIT       1      ?       Mitochondrion. {ECO:0000255}.
FT   CHAIN         ?    467       Hydroxyacid-oxoacid transhydrogenase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000322996.
FT   MOD_RES     445    445       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8R0N6}.
FT   MOD_RES     452    452       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8R0N6}.
FT   VAR_SEQ       1     48       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:12592711,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_031984.
FT   VAR_SEQ     299    303       RNPDD -> NSTDK (in isoform 3 and isoform
FT                                4). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_031985.
FT   VAR_SEQ     304    467       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_031986.
FT   VARIANT     242    242       D -> V (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_039470.
FT   VARIANT     449    449       C -> R (in dbSNP:rs1060242).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15221005}.
FT                                /FTId=VAR_054015.
SQ   SEQUENCE   467 AA;  50308 MW;  C66E0EB15610A0E3 CRC64;
     MAAAARARVA YLLRQLQRAA CQCPTHSHTY SQAPGLSPSG KTTDYAFEMA VSNIRYGAAV
     TKEVGMDLKN MGAKNVCLMT DKNLSKLPPV QVAMDSLVKN GIPFTVYDNV RVEPTDSSFM
     EAIEFAQKGA FDAYVAVGGG STMDTCKAAN LYASSPHSDF LDYVSAPIGK GKPVSVPLKP
     LIAVPTTSGT GSETTGVAIF DYEHLKVKIG ITSRAIKPTL GLIDPLHTLH MPARVVANSG
     FDVLCHALES YTTLPYHLRS PCPSNPITRP AYQGSNPISD IWAIHALRIV AKYLKRAVRN
     PDDLEARSHM HLASAFAGIG FGNAGVHLCH GMSYPISGLV KMYKAKDYNV DHPLVPHGLS
     VVLTSPAVFT FTAQMFPERH LEMAEILGAD TRTARIQDAG LVLADTLRKF LFDLDVDDGL
     AAVGYSKADI PALVKGTLPQ ERVTKLAPCP QSEEDLAALF EASMKLY
//
